author-photo

Darryl Maher

CSL Limited

38

Papers

4342

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

The use of hyperimmune serum for severe influenza infections

2012 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (12)
Efficacy, Safety and Pharmacokinetics of a Novel Subcutaneous Immunoglobulin, Evogam ® , in Primary Immunodeficiency

2012 Journal of Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (5)
inducible (metallothionein) promoter lines transformed by SV40 large T antigen under the influence of an Support of human cord blood progenitor cells on human stromal cell

2010
Show All
- Source
- Cite
- Save
Citations (0)
Differential alterations in plasma colony‐stimulating factor concentrations in meningococcaemia

2008 Clinical and Experimental Immunology
Show All
- Source
- Cite
- Save
Citations (31)
Erratum: Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans (Proceedings of the National Academy of Sciences of the United States of America (July 20, 2004) 101, 29 (10697-10702))

2005 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (4)
Recombinant NY‐ESO‐1 Cancer Antigen: Production and Purification under cGMP Conditions

2005 Preparative Biochemistry & Biotechnology
Show All
- Source
- Cite
- Save
Citations (37)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

2004 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (406)
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

2004 Vaccine
Show All
- Source
- Cite
- Save
Citations (158)
A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer

2000 Growth Factors Journal
Show All
- Source
- Cite
- Save
Citations (8)
Multicycle High-Dose Chemotherapy and Filgrastim-Mobilized Peripheral-Blood Progenitor Cells in Women With High-Risk Stage II or III Breast Cancer: Five-Year Follow-Up

1999 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (25)